Reference
Kowalski M, et al. Polypharmacy: A risk factor to consider in valproate-induced hyperammonaemic encephalopathy. Journal of Pharmacy Practice and Research 45: 433-436, No. 4, Dec 2015. Available from: URL: http://doi.org/10.1002/jppr.1108 - Australia
Rights and permissions
About this article
Cite this article
Atorvastatin/topiramate/valproate. Reactions Weekly 1592, 39 (2016). https://doi.org/10.1007/s40278-016-15467-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-15467-9